Stay updated with breaking news from Shira Dinner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Topline data from the randomized Phase 2b KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer expected in early April 2024 Median progression free survival of...
Topline data from the randomized Phase 2b KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer (NSCLC) expected in early April 2024
Topline data from the randomized Phase 2b KICKSTART trial of tomivosertib combined with pembrolizumab in non-small cell lung cancer (NSCLC) expect...
13.11.2023 - Management intends to provide an update on its zotatifin clinical development program in estrogen receptor-positive (ER+) metastatic breast cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium (SABCS) Topline results from Phase 2b KICKSTART ...
Trial designed to capitalize on previously published results that showed preclinical activity of tomivosertib in AML modelsSOLANA BEACH, Calif. and REDWOOD CITY, Calif., Oct. 24, 2023 -- eFFECTOR...